Your browser doesn't support javascript.
loading
Controlling genetic heterogeneity in gene-edited hematopoietic stem cells by single-cell expansion.
Becker, Hans Jiro; Ishida, Reiko; Wilkinson, Adam C; Kimura, Takaharu; Lee, Michelle Sue Jann; Coban, Cevayir; Ota, Yasunori; Tanaka, Yosuke; Roskamp, Meike; Sano, Tsubasa; Tojo, Arinobu; Kent, David G; Yamazaki, Satoshi.
Afiliação
  • Becker HJ; Laboratory for Stem Cell Therapy, Faculty of Medicine, Tsukuba University, Tsukuba 305-8577, Japan; Division of Stem Cell Biology, Center for Stem Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan. Electronic address: jiro.becker@md.tsukuba.ac.jp.
  • Ishida R; Division of Stem Cell Biology, Center for Stem Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Wilkinson AC; MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, UK.
  • Kimura T; Laboratory for Stem Cell Therapy, Faculty of Medicine, Tsukuba University, Tsukuba 305-8577, Japan.
  • Lee MSJ; Division of Malaria Immunology and International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Coban C; Division of Malaria Immunology and International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Ota Y; Department of Pathology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
  • Tanaka Y; International Research Center for Medical Sciences, Kumamoto University, Kumamoto City 860-0811, Japan.
  • Roskamp M; Pharma Solutions, Nutrition & Health, BASF SE, Carl-Bosch-Strasse 38, 67056 Ludwigshafen am Rhein, Germany.
  • Sano T; Pharma Solutions, Nutrition & Health, BASF Japan Ltd, Tokyo 103-0022, Japan.
  • Tojo A; Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
  • Kent DG; York Biomedical Research Institute, Department of Biology, University of York, Wentworth Way, York YO10 5DD, UK.
  • Yamazaki S; Laboratory for Stem Cell Therapy, Faculty of Medicine, Tsukuba University, Tsukuba 305-8577, Japan; Division of Stem Cell Biology, Center for Stem Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan. Electronic address: y-sato4@md.tsukuba.ac.jp.
Cell Stem Cell ; 30(7): 987-1000.e8, 2023 07 06.
Article em En | MEDLINE | ID: mdl-37385251
Gene editing using engineered nucleases frequently produces unintended genetic lesions in hematopoietic stem cells (HSCs). Gene-edited HSC cultures thus contain heterogeneous populations, the majority of which either do not carry the desired edit or harbor unwanted mutations. In consequence, transplanting edited HSCs carries the risks of suboptimal efficiency and of unwanted mutations in the graft. Here, we present an approach for expanding gene-edited HSCs at clonal density, allowing for genetic profiling of individual clones before transplantation. We achieved this by developing a defined, polymer-based expansion system and identifying long-term expanding clones within the CD201+CD150+CD48-c-Kit+Sca-1+Lin- population of precultured HSCs. Using the Prkdcscid immunodeficiency model, we demonstrate that we can expand and profile edited HSC clones to check for desired and unintended modifications, including large deletions. Transplantation of Prkdc-corrected HSCs rescued the immunodeficient phenotype. Our ex vivo manipulation platform establishes a paradigm to control genetic heterogeneity in HSC gene editing and therapy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Edição de Genes Idioma: En Revista: Cell Stem Cell Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Edição de Genes Idioma: En Revista: Cell Stem Cell Ano de publicação: 2023 Tipo de documento: Article